Skip to main content
Clinical Trials/ACTRN12609000713291
ACTRN12609000713291
Terminated
未知

Cerebral palsy and electrical stimulation - does stimulation of the gastrocnemius muscle pre- and post-botulinum toxin A injection for dynamic equinus facilitate greater uptake of the toxin when measured by clinical examination and 3-D gait analysis?

Women's and Children's Hospital0 sites50 target enrollmentAugust 18, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Cerebral palsy, both hemiplegic and diplegic conditions, in children aged 4-12 years old.
Sponsor
Women's and Children's Hospital
Enrollment
50
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 18, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Women's and Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Children between the ages of 4 and 12 years with a confirmed diagnosis of spastic hemiplegic or spastic diplegic cerebral palsy (CP)
  • 2\. Planned injection of gastrocnemius muscle for the treatment of dynamic equinus deformity
  • 3\. Walking ability described by classification at Gross Motor Functional Classification System (GMFCS) levels one to three (walks independently or with assistive devices)
  • 4\. Ongoing participation in a community\-based therapy programme.

Exclusion Criteria

  • 1\. Previous lower limb surgery involving the calf and/or hamstring
  • 2\. Use of botox A in the calf muscle within the last six months
  • 3\. Inability to follow a single stage command
  • 4\. Inability to walk along a 10m walk way for a total of five trials
  • 5\. Presence of fixed muscle contractures.
  • 6\. Casting post\-botox injection

Outcomes

Primary Outcomes

Not specified

Similar Trials